Posted on Wednesday, February 05, 2014 at 11:35 am CST
Global Markets Direct's, 'Emesis (Vomiting) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Emesis (Vomiting), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Emesis (Vomiting). Emesis (Vomiting) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:30 am CST
Global Markets Direct's, 'Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Neuromyelitis Optica (Devic's Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuromyelitis Optica (Devic's Syndrome). Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:29 am CST
Global Market Direct's pharmaceuticals report, "Mycenax Biotech Inc. - Product Pipeline Review - 2013" provides data on the Mycenax Biotech Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:29 am CST
Global Markets Direct's, 'Community-Acquired Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. Community-Acquired Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:25 am CST
Global Market Direct's pharmaceuticals report, "Adherex Technologies Inc. - Product Pipeline Review - 2013" provides data on the Adherex Technologies Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:23 am CST
Global Markets Direct's, 'Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency). Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:20 am CST
Global Markets Direct's, 'Mycosis Fungoides - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Mycosis Fungoides, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mycosis Fungoides. Mycosis Fungoides - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:05 am CST
Global Market Direct's pharmaceuticals report, "Serometrix, LLC - Product Pipeline Review - 2013" provides data on the Serometrix, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:04 am CST
Global Markets Direct's, 'Myotonic Dystrophy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Myotonic Dystrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myotonic Dystrophy. Myotonic Dystrophy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 11:02 am CST
Global Markets Direct's, 'Spinocerebellar Ataxias - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Spinocerebellar Ataxias, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinocerebellar Ataxias. Spinocerebellar Ataxias - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 10:56 am CST
Global Market Direct's pharmaceuticals report, "EyeGene, Inc. - Product Pipeline Review - 2013" provides data on the EyeGene, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 10:53 am CST
Global Market Direct's pharmaceuticals report, "KaloBios Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the KaloBios Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 10:40 am CST
Global Markets Direct's, 'Thyroid Cancer - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Thyroid Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Thyroid Cancer. Thyroid Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 10:27 am CST
Global Market Direct's pharmaceuticals report, "sterna biologicals Gmbh & Co KG - Product Pipeline Review - 2013" provides data on the sterna biologicals Gmbh & Co KG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 10:10 am CST
Global Market Direct's pharmaceuticals report, "IPCA Laboratories Limited - Product Pipeline Review - 2013" provides data on the IPCA Laboratories Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 10:02 am CST
Global Market Direct's pharmaceuticals report, "Myomics, Inc. - Product Pipeline Review - 2013" provides data on the Myomics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:56 am CST
Global Market Direct's pharmaceuticals report, "Metabolic Solutions Development Co. - Product Pipeline Review - 2013" provides data on the Metabolic Solutions Development Co.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:50 am CST
Global Market Direct's pharmaceuticals report, "Vichem Chemie Research Ltd. - Product Pipeline Review - 2013" provides data on the Vichem Chemie Research Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:42 am CST
Global Markets Direct's, 'High-Grade Glioma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for High-Grade Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for High-Grade Glioma. High-Grade Glioma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:32 am CST
Global Market Direct's pharmaceuticals report, "Bharat Biotech International Limited - Product Pipeline Review - 2013" provides data on the Bharat Biotech International Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:26 am CST
Global Market Direct's pharmaceuticals report, "PharmEste - Product Pipeline Review - 2013" provides data on the PharmEste's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:17 am CST
Global Market Direct's pharmaceuticals report, "HealOr Ltd. - Product Pipeline Review - 2013" provides data on the HealOr Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:16 am CST
Global Market Direct's pharmaceuticals report, "Valentia Biopharma S.L. - Product Pipeline Review - 2013" provides data on the Valentia Biopharma S.L.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:09 am CST
Global Market Direct's pharmaceuticals report, "ProteoTech, Inc. - Product Pipeline Review - 2013" provides data on the ProteoTech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 05, 2014 at 9:07 am CST
Global Market Direct's pharmaceuticals report, "Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the Deciphera Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research